Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.

Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.

The cyclin-dependent kinase inhibitor p27(Kip1) (p27) plays a pivotal role in controlling cell proliferation during development and tumorigenesis. p27 has been implicated in pituitary tumorigenesis in studies of knockout mice and in analyses of human pituitary tumor samples. In this study, we furthe...

Bibliografski detalji
Glavni autori:	Korbonits, M, Chahal, H, Kaltsas, G, Jordan, S, Urmanova, Y, Khalimova, Z, Harris, P, Farrell, W, Claret, F, Grossman, AB
Format:	Journal article
Jezik:	English
Izdano:	2002

Slični predmeti

Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
od: Lidhar, K, i dr.
Izdano: (1999)

Cyclins and their related proteins in pituitary tumourigenesis.
od: Muşat, M, i dr.
Izdano: (2010)

Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
od: Dahia, P, i dr.
Izdano: (1998)

p27<sup>Kip1</sup>, an Intrinsically Unstructured Protein with Scaffold Properties
od: Debora Bencivenga, i dr.
Izdano: (2021-08-01)

Role of T198 modification in the regulation of p27(Kip1) protein stability and function.
od: Monica Schiappacassi, i dr.
Izdano: (2011-03-01)

Phosphorylation and subcellular localization of p27Kip1 regulated by hydrogen peroxide modulation in cancer cells.
od: Irene L Ibañez, i dr.
Izdano: (2012-01-01)

p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer
od: Gian Luca Rampioni Vinciguerra, i dr.
Izdano: (2021-10-01)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
od: Korbonits, M, i dr.
Izdano: (1999)

Forkhead Box O1 is present in quiescent pituitary cells during development and is increased in the absence of p27 Kip1.
od: Sreeparna Majumdar, i dr.
Izdano: (2012-01-01)

Malignant pituitary tumours.
od: Kaltsas, G, i dr.
Izdano: (1998)

Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
od: Erdamar, S, i dr.
Izdano: (1999)

Akt1 sequentially phosphorylates p27<sup>kip1 </sup>within a conserved but non-canonical region
od: Nacusi Lucas P, i dr.
Izdano: (2006-06-01)

The expression of the F-box protein Skp2 is negatively associated with p27 expression in human pituitary tumors.
od: Musat, M, i dr.
Izdano: (2002)

Leptin in pituitary adenomas--a novel paracrine regulatory system.
od: Korbonits, M, i dr.
Izdano: (2001)

The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.
od: Le, X, i dr.
Izdano: (2011)

Cyclin E and p27/Kip1: two proteins on a see-saw or another false dawn?
od: Chetty, R
Izdano: (2002)

Akting and cycling: a tale of the pituitary.
od: Grossman, AB, i dr.
Izdano: (2004)

Screening For Small Molecule Inhibitors Of p27Kip1 Degradation
od: Ooi, Li Ching
Izdano: (2012)

p27KIP1 Deletions in Childhood Acute Lymphoblastic Leukemia
od: Hiroaki Komuro, i dr.
Izdano: (1999-08-01)

p27kip1 at the crossroad between actin and microtubule dynamics
od: Gian Luca Rampioni Vinciguerra, i dr.
Izdano: (2019-04-01)

Regulation of p27<sup>Kip1</sup> and p57<sup>Kip2</sup> Functions by Natural Polyphenols
od: Gian Luigi Russo, i dr.
Izdano: (2020-09-01)

Docosahexaenoic acid inhibits cancer cell growth via p27Kip1, CDK2, ERK1/ERK2, and retinoblastoma phosphorylation
od: Naim A. Khan, i dr.
Izdano: (2006-10-01)

Enhanced protein kinase B/Akt signalling in pituitary tumours.
od: Musat, M, i dr.
Izdano: (2005)

In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.
od: Cornelissen, B, i dr.
Izdano: (2009)

Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
od: Kaltsas, G, i dr.
Izdano: (2002)

p27(kip1) localisation is an independent prognostic marker for colorectal cancer.
od: Royds, J, i dr.
Izdano: (1997)

Akt/p27kip1 Pathway Is Not Involved in Human Insulinoma Tumorigenesis
od: Adriana Graciela Díaz, i dr.
Izdano: (2018-01-01)

p27<sup>kip1</sup>: a target for tumor therapies?
od: Kossatz Uta, i dr.
Izdano: (2007-05-01)

Cyclin D and cyclin E expression in normal and adenomatous pituitary.
od: Jordan, S, i dr.
Izdano: (2000)

FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27Kip1 in acute myeloid leukemia
od: Ines Peschel, i dr.
Izdano: (2017-08-01)

MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
od: Trivellin, G, i dr.
Izdano: (2012)

Endotoxin induces interleukin-1beta and nitric oxide synthase mRNA in rat hypothalamus and pituitary.
od: Satta, M, i dr.
Izdano: (1998)

KINASE INHIBITOR PROTEIN-1 (Kip-1) SEBAGAI BIOMARKER RISIKO KEGANASAN LEUKOPLAKIA
od: , Supriatno, i dr.
Izdano: (2012)

Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway
od: S.Y. Cong, i dr.
Izdano: (2012-06-01)

Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
od: Gillett, C, i dr.
Izdano: (1999)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
od: Korbonits, M, i dr.
Izdano: (1999)

Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
od: Igreja, S, i dr.
Izdano: (2009)

EpoR Activation Stimulates Erythroid Precursor Proliferation by Inducing Phosphorylation of Tyrosine-88 of the CDK-Inhibitor p27<sup>Kip1</sup>
od: Fragka Pegka, i dr.
Izdano: (2023-06-01)

Regulation of p27 (Kip1) by Ubiquitin E3 Ligase RNF6
od: Dhanraj Deshmukh, i dr.
Izdano: (2022-04-01)

Cell type-specific effects of p27KIP1 loss on retinal development
od: Mariko Ogawa, i dr.
Izdano: (2017-09-01)